Peer-reviewedCC BYBiomedicines
Five Decades of Infusion Testing in Idiopathic Normal-Pressure Hydrocephalus: Resistance to CSF Outflow as a Biomarker in Search of a Gold Standard
- 1Neurotraumatology and Neurosurgery Research Unit, Vall d’Hebron Institut de Recerca (VHIR), Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain;
- 2ICFO-Institut de Ciències Fotòniques, 08860 Castelldefels, Spain; (M.T.-V.-l.); (T.D.)
Related
- Outcomes of a care bundle strategy at a dedicated private surgical center for idiopathic normal pressure hydrocephalus
- A Frailty-integrated Prognostic Prediction Tool for Long-term Outcomes after Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus: Development and Prospective Validation
- Paired CSF and plasma metabolomics reveals a robust CSF-centered metabolic phenotype in idiopathic normal-pressure hydrocephalus: an exploratory case-control study
- Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy
- FABP3, a Candidate Biomarker of Muscle Strength and Myositis Disease Activity in Patients with Idiopathic Inflammatory Myopathies
BibTeX
@article{sahuquillo2026five,
title = {{Five Decades of Infusion Testing in Idiopathic Normal-Pressure Hydrocephalus: Resistance to CSF Outflow as a Biomarker in Search of a Gold Standard}},
author = {Juan Sahuquillo and Murad Al-Nusaif and Monica Torrecilla-Vall-llossera and Turgut Durduran and Maria-A. Poca},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701216},
note = {CC BY},
}
RIS
TY - JOUR
TI - Five Decades of Infusion Testing in Idiopathic Normal-Pressure Hydrocephalus: Resistance to CSF Outflow as a Biomarker in Search of a Gold Standard
AU - Juan Sahuquillo
AU - Murad Al-Nusaif
AU - Monica Torrecilla-Vall-llossera
AU - Turgut Durduran
AU - Maria-A. Poca
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701216
SN - 2227-9059
ER -